Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
137M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
2.07M
-
Shares change
-
+322K
-
Total reported value, excl. options
-
$1.69M
-
Value change
-
+$171K
-
Number of buys
-
17
-
Number of sells
-
-8
-
Price
-
$0.81
Significant Holders of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) as of Q1 2024
28 filings reported holding LUCD - Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.07M shares
of 137M outstanding shares and own 1.51% of the company stock.
Largest 10 shareholders include LUMINUS MANAGEMENT LLC (718K shares), VANGUARD GROUP INC (561K shares), GEODE CAPITAL MANAGEMENT, LLC (156K shares), Nantahala Capital Management, LLC (150K shares), JANE STREET GROUP, LLC (122K shares), HRT FINANCIAL LP (63K shares), BlackRock Inc. (51.6K shares), Verition Fund Management LLC (42.4K shares), LPL Financial LLC (37K shares), and Virtu Financial LLC (34.7K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.